State-dependent effects of the D2 partial agonist aripiprazole on dopamine neuron activity in the MAM neurodevelopmental model of schizophrenia
出版年份 2018 全文链接
标题
State-dependent effects of the D2 partial agonist aripiprazole on dopamine neuron activity in the MAM neurodevelopmental model of schizophrenia
作者
关键词
-
出版物
NEUROPSYCHOPHARMACOLOGY
Volume -, Issue -, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-09-18
DOI
10.1038/s41386-018-0219-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy
- (2017) Guy Chouinard et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Reduction of Severity of Recurrent Psychotic Episode by Sustained Treatment with Aripiprazole in a Schizophrenic Patient with Dopamine Supersensitivity: A Case Report
- (2017) Shigenori Tadokoro et al. Clinical Psychopharmacology and Neuroscience
- New functional activity of aripiprazole revealed: Robust antagonism of D2 dopamine receptor-stimulated Gβγ signaling
- (2015) Tarsis F. Brust et al. BIOCHEMICAL PHARMACOLOGY
- Dopamine supersensitivity psychosis and dopamine partial agonist: A retrospective survey of failure of switching to aripiprazole in schizophrenia
- (2015) Masayuki Takase et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Translating the MAM model of psychosis to humans
- (2015) Gemma Modinos et al. TRENDS IN NEUROSCIENCES
- Alterations in dopamine system function across the estrous cycle of the MAM rodent model of schizophrenia
- (2014) Stephanie M. Perez et al. PSYCHONEUROENDOCRINOLOGY
- Prior Antipsychotic Drug Treatment Prevents Response to Novel Antipsychotic Agent in the Methylazoxymethanol Acetate Model of Schizophrenia
- (2014) K. M. Gill et al. SCHIZOPHRENIA BULLETIN
- Imaging Patients with Psychosis and a Mouse Model Establishes a Spreading Pattern of Hippocampal Dysfunction and Implicates Glutamate as a Driver
- (2013) Scott A. Schobel et al. NEURON
- Peripubertal Diazepam Administration Prevents the Emergence of Dopamine System Hyperresponsivity in the MAM Developmental Disruption Model of Schizophrenia
- (2013) Yijuan Du et al. NEUROPSYCHOPHARMACOLOGY
- Are you or aren’t you? Challenges associated with physiologically identifying dopamine neurons
- (2012) Mark A. Ungless et al. TRENDS IN NEUROSCIENCES
- Antipsychotic Drugs Rapidly Induce Dopamine Neuron Depolarization Block in a Developmental Rat Model of Schizophrenia
- (2011) O. Valenti et al. JOURNAL OF NEUROSCIENCE
- Chronic Treatment With Aripiprazole Prevents Development of Dopamine Supersensitivity and Potentially Supersensitivity Psychosis
- (2011) S. Tadokoro et al. SCHIZOPHRENIA BULLETIN
- Differential Targeting of the CA1 Subfield of the Hippocampal Formation by Schizophrenia and Related Psychotic Disorders
- (2009) Scott A. Schobel et al. ARCHIVES OF GENERAL PSYCHIATRY
- A Loss of Parvalbumin-Containing Interneurons Is Associated with Diminished Oscillatory Activity in an Animal Model of Schizophrenia
- (2009) D. J. Lodge et al. JOURNAL OF NEUROSCIENCE
- A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia
- (2008) Stefan Leucht et al. AMERICAN JOURNAL OF PSYCHIATRY
- Less Is More: Antipsychotic Drug Effects Are Greater with Transient Rather Than Continuous Delivery
- (2008) Anne-Noël Samaha et al. BIOLOGICAL PSYCHIATRY
- Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
- (2008) Stefan Leucht et al. LANCET
- Atypical Antipsychotics: CATIE Study, Drug-Induced Movement Disorder and Resulting Iatrogenic Psychiatric-Like Symptoms, Supersensitivity Rebound Psychosis and Withdrawal Discontinuation Syndromes
- (2008) Guy Chouinard et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started